In light of the incessant healthcare talk and reform on the imminent horizon, we’ve lately had fun discovering tiny new companies that illustrate some of the under-the-radar efforts of the medical community that might help reduce the cost of what has become a behemoth. (Oh, Congress, are you listening?) This week, that company [...]
Noted with increasing frequency of late are the healthcare implications of the aging baby boomer generation. Everything from Medicare costs to drug development direction will be affected by this trend, and our own clients in the medical devices space are practically giddy with anticipation. Indeed, the device market is expected to double within [...]
Late last week, a little company in Newport, R.I. made a big announcement; namely, that it had nabbed $11.6 million in a Series A funding round for its snake robot technology for minimally-invasive surgical procedures. Given the severely sluggish VC market and what feels like a dearth of new deals the past two quarters, this [...]
Waltham, MA-based medical device company Augmenix has allegedly sealed up $4.7 million of a planned $7.5 million round of funding this week, according to Mass High Tech. The company, while still rather under the radar given its sparse website, sounds promising: begun by serial life sciences entrepreneur Amar Sawhney, it is developing space-filling hydrogels [...]
FierceBiotech today released its annual Fierce 15 list of the top fifteen emerging biotech companies, and editor John Carroll’s commentary on this year’s selection process was a bit surprising. In contrast to his initial fear, he says it was unexpectedly easy to find the top outfits, even given the rather disheartening state of the [...]
A Cambridge-based biopharma, developing a revolutionary class of drugs called Stapled Peptides, received some major backing from big pharma today. Fierce Biotech reported that Aileron Therapeutics landed $40 million in Series D funding from the venture arms of four of the world’s biggest pharma companies, including SR One (the corporate venture fund of GlaxoSmithKline), Novartis [...]
Newton, MA-based Life Image Inc. landed in the news this week for a $2.2 million round of funding as reported by Mass High Tech. The company calls itself the “Universal Imaging Inbox” on its website, and it certainly doesn’t look too hard to understand the value of its technology. The startup’s web-based applications and services [...]
Yesterday, we announced $500,000 in seed funding for new medical software startup RxVantage. The company is growing fast (a 90% acceptance rate of its signature application among early adopters has accelerated outreach), and the investment, which the company hopes will be a part of a much larger ($6-8 million) round within the next few months, [...]
We’ve become accustomed to hearing about advancements in the life sciences industry from places like California, Massachusetts and North Carolina, but today’s interesting news clip comes from, drum roll please…Alabama. You may be asking yourself, just what new and exciting company is on the horizon in Alabama? Well, the answer is several; at least that’s [...]
More positive news for bio-tech in New England!
Even as the economy shrinks and VC money gets harder to come by, innovation is still be nurtured and rewarded for local life sciences companies. According to Mass High Tech today, Proteon Therapeutics, Inc. has completed a second closing of its Series B equity financing, raising an additional [...]